Predisposing factors to pattern change in cervical dystonia.
Abstract
[BACKGROUND] Cervical dystonia (CD) patterns may change with Botulinum toxin (BoNT) treatment.
[OBJECTIVE] To evaluate the time within those changes usually occur, the most predisposed phenotypes and predisposing factors.
[METHODS] We divided idiopathic CD patients into two groups- change YES and NO, collecting general clinical and demographic variables. We also evaluated duration of BoNT treatment, Tsui total scores and subscores - assessed at T0 - before BoNT start - and at T1- time to chenge in the YES group or last visit in the NO group. The risk of pattern change was assessed by Kaplan Meyer curves and Cox regression analysis. Finally, Multivariate linear regressions were employed to assess if Tsui severity correlated with the change.
[RESULTS] Among 100 patients (60 women), 37 experienced a phenotype switch, mostly in the first five years of BoNT treatment, YES and NO groups were comparable. Multivariate Cox Regression revealed the presence of laterocollis or rotatocollis at T0 as predictors of switch (respectively P = 0.01, HR = 3.5; P = 0.03, HR = 1.5). Multivariate linear regressions revealed that high Tsui subscores for the tilt and low Tsui total scores were risk factors for the change of pattern (respectively P = 0.002, OR = 6; P = 0.03, OR = 0.8).
[CONCLUSIONS] Latero and Rotatocollis are the CD phenotypes most predisposed to change. CD characterized by neck tilt are more likely to change phenotype following treatment. Dystonias with a low degree of severity are more predisposed to switch. Both, the different degree of muscle activation and BoNT mechanism of action, may impact on that phenomenon.
[OBJECTIVE] To evaluate the time within those changes usually occur, the most predisposed phenotypes and predisposing factors.
[METHODS] We divided idiopathic CD patients into two groups- change YES and NO, collecting general clinical and demographic variables. We also evaluated duration of BoNT treatment, Tsui total scores and subscores - assessed at T0 - before BoNT start - and at T1- time to chenge in the YES group or last visit in the NO group. The risk of pattern change was assessed by Kaplan Meyer curves and Cox regression analysis. Finally, Multivariate linear regressions were employed to assess if Tsui severity correlated with the change.
[RESULTS] Among 100 patients (60 women), 37 experienced a phenotype switch, mostly in the first five years of BoNT treatment, YES and NO groups were comparable. Multivariate Cox Regression revealed the presence of laterocollis or rotatocollis at T0 as predictors of switch (respectively P = 0.01, HR = 3.5; P = 0.03, HR = 1.5). Multivariate linear regressions revealed that high Tsui subscores for the tilt and low Tsui total scores were risk factors for the change of pattern (respectively P = 0.002, OR = 6; P = 0.03, OR = 0.8).
[CONCLUSIONS] Latero and Rotatocollis are the CD phenotypes most predisposed to change. CD characterized by neck tilt are more likely to change phenotype following treatment. Dystonias with a low degree of severity are more predisposed to switch. Both, the different degree of muscle activation and BoNT mechanism of action, may impact on that phenomenon.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | botulinum toxin
|
보툴리눔독소 주사 | dict | 1 | |
| 해부 | cervical
|
scispacy | 1 | ||
| 해부 | muscle
|
scispacy | 1 | ||
| 약물 | BoNT
→ Botulinum toxin
|
C0006055
Botulinum Toxins
|
scispacy | 1 | |
| 약물 | [BACKGROUND] Cervical dystonia
|
scispacy | 1 | ||
| 약물 | [CONCLUSIONS] Latero
|
scispacy | 1 | ||
| 질환 | dystonia
|
C0013421
Dystonia
|
scispacy | 1 | |
| 질환 | idiopathic CD
|
scispacy | 1 | ||
| 질환 | Dystonias
|
C0013421
Dystonia
|
scispacy | 1 | |
| 질환 | T1-
|
scispacy | 1 | ||
| 기타 | BoNT
→ Botulinum toxin
|
scispacy | 1 |
MeSH Terms
Humans; Torticollis; Female; Male; Middle Aged; Adult; Aged; Severity of Illness Index; Neuromuscular Agents; Botulinum Toxins; Disease Progression
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis.
- Decreased utilization of component separation techniques over time in complex abdominal wall reconstruction following introduction of preoperative botulinum toxin A.
- Current Perspectives on Pectoralis Minor Syndrome: A Narrative Review.